SAVA

About:

The first effortless continuous molecular tracker unlocking human perfomance

Top Investors: Exor Ventures, SOSV, Balderton Capital, Social Starts, Exceptional Ventures

Description:

All the health information we need is within us. Just below the skin. SAVA is redefining the way people interact with their health by developing the most advanced biosensing technology science has to offer, capable of accessing bodily information in a painless, real-time and affordable way.

Total Funding Amount:

6.3M GBP

Estimated Revenue Range:

Less than $1M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2016-11-28

Contact Email:

emma(AT)caura.me

Founders:

Rafael Michaeli, Renato Circi

Number of Employees:

1-10

Last Funding Date:

2024-06-21

IPO Status:

Private

Industries: